4.
两组治疗前后血脂水平的变化
Effect of the therapies on metabolic parameters (Mean± SD)
| Parameter | Baseline | 3 months | 6 months |
| There was a significant difference before and during treatment, *P < 0.05; The difference was statistically significant between 3 months and 6 moths of treatment, #P < 0.05. | |||
| FPG (mmol/L) | |||
| Group A | 5.43±0.54 | 5.34±0.50 | 5.28±0.43* |
| Group B | 5.34±0.46 | 5.22±0.47 | 5.10±0.44* |
| TCh (mmol/L) | |||
| Group A | 4.21±0.96 | 4.94±0.79* | 4.78±1.29* |
| Group B | 4.53±0.96 | 4.92±1.10* | 4.84±0.93* |
| TG (mmol/L) | |||
| Group A | 1.24±0.88 | 1.71±1.59* | 1.68±1.02* |
| Group B | 1.29±0.71 | 1.47±0.64* | 1.67±0.82* |
| HDL (mmol/L) | |||
| Group A | 1.57±0.34 | 1.81±0.45* | 1.84±0.48* |
| Group B | 1.48±0.29 | 1.65±0.37* | 1.64±0.38* |
| LDL (mmol/L) | |||
| Group A | 2.46±0.70 | 2.70±0.67* | 2.69±0.85 |
| Group B | 2.71±1.00 | 2.90±1.06* | 2.80±0.86 |
| AIP | |||
| Group A | -0.15±0.28 | -0.07±0.27* | -0.08±0.26* |
| Group B | -0.12±0.27 | -0.08±0.22 | -0.04±0.24*# |